15 July: Understanding generic and biosimilar market entry,safe use of transdermal patches, & events

NHS Specialist Pharmacy Service

Madeleine Foster, Chief Pharmaceutical Officer’s Clinical Fellow at SPS, presents a summary of the resources published by SPS between 5th July and 11th July. To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.    Quick links to highlighted resources:      Understanding generic and biosimilar market entry New medicines have several protections against competition. Other factors influence availability of generics or biosimilars after loss of exclusivity. https://www.sps.nhs.uk/articles/understanding-generic-and-biosimilar-market-entry/ Understanding data exclusivity and market protection Data exclusivity and market protection periods prevent generic or biosimilar competition for at least 10 years after the originator medicine is licensed. https://www.sps.nhs.uk/articles/understanding-data-exclusivity-and-market-protection/ Understanding patents Patents allow the inventor a finite period of monopoly in exchange for publicising the idea. We explain how they work with respect to medicines. https://www.sps.nhs.uk/articles/understanding-patents/ Using transdermal patches safely in healthcare settings Practical guidance for safe application, monitoring, removal, disposal, documentation and storage of transdermal patches to reduce risk of medication errors. https://www.sps.nhs.uk/articles/using-transdermal-patches-safely-in-healthcare-settings/ Prescribing and switching between modified-release methylphenidate Modified-release methylphenidate capsules and tablets differ. Ensure patients receive appropriate treatment, particularly during periods of supply disruption. https://www.sps.nhs.uk/articles/prescribing-and-switching-between-modified-release-methylphenidate/ Hydromorphone: informing intrathecal risk assessment Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration. https://www.sps.nhs.uk/articles/hydromorphone-informing-intrathecal-risk-assessment/ Anticoagulant suggestions for adults with swallowing difficulties A range of oral anticoagulant formulations are suitable for adults with swallowing difficulties. https://www.sps.nhs.uk/articles/anticoagulant-suggestions-for-adults-with-swallowing-difficulties/ Next events – forthcoming webinars and conferences      https://www.sps.nhs.uk/home/events/next-events/      Podcast description:    NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.